Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients.

Autor: Halámková J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.; Department of Medical Ethics, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Bohovicová L; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Pehalová L; Institute of Health Information and Statistics of the Czech Republic, 128 01 Prague, Czech Republic.; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Goněc R; Department of Pharmacy, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic., Staněk T; Department of Surgical Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.; Department of Surgical Oncology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Kazda T; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.; Department of Radiation Oncology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Mouková L; Department of Surgical Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic., Krákorová DA; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic., Kozáková Š; Department of Pharmacy, University Hospital Brno, 625 00 Brno, Czech Republic.; Department of Pharmacology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Svoboda M; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Demlová R; Department of Pharmacology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.; Clinical Trial Unit, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic., Kiss I; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.

Publikováno v: Cancers [Cancers (Basel)] 2022 Mar 27; Vol. 14 (7). Date of Electronic Publication: 2022 Mar 27.

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Autor: Strauss SJ; Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK., Frezza AM; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Abecassis N; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon, Portugal., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Bauer S; Department of Medical Oncology, Interdisciplinary Sarcoma Center, West German Cancer Center, University of Duisburg-Essen, Essen, Germany., Biagini R; Department of Oncological Orthopedics, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bielack S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany., Blay JY; Centre Leon Berard and UCBL1, Lyon, France., Bolle S; Radiation Oncology Department, Gustave Roussy, Villejuif, France., Bonvalot S; Department of Surgery, Institut Curie, Paris, France., Boukovinas I; Bioclinic Thessaloniki, Thessaloniki, Greece., Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Boye K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Brennan B; Paediatric Oncology, Royal Manchester Children's Hospital, Manchester, UK., Brodowicz T; Vienna General Hospital (AKH), Medizinische Universität Wien, Vienna, Austria., Buonadonna A; Centro di Riferimento Oncologico di Aviano, Aviano, Italy., de Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital, CSIC, University of Sevilla, CIBERONC, Seville, Spain; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain., Dei Tos AP; Department of Pathology, Azienda Ospedale Università Padova, Padua, Italy., Garcia Del Muro X; Integrated Unit ICO Hospitalet, HUB, Barcelona, Spain., Dufresne A; Département d'Oncologie Médicale Centre Leon Berard, Lyon, France., Eriksson M; Skane University Hospital-Lund, Lund, Sweden., Fagioli F; Paediatric Onco-Haematology Department, Regina Margherita Children's Hospital, Department of Public Health and Pediatrics, University of Turin, Turin, Italy., Fedenko A; P.A. Herzen Cancer Research Institute, Moscow, Russian Federation., Ferraresi V; Sarcomas and Rare Tumors Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gaspar N; Department of Oncology for Child and Adolescents, Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif, France., Gasperoni S; Department of Oncology and Robotic Surgery, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Gouin F; Centre Leon-Berard Lyon, Lyon, France., Grignani G; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Haas R; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands., Hassan AB; Oxford University Hospitals NHS Foundation Trust and University of Oxford, Oxford, UK., Hecker-Nolting S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany., Hindi N; Department of Medical Oncology, Fundación Jimenez Diaz, University Hospital, Advanced Therapies in Sarcoma Lab, Madrid, Spain., Hohenberger P; Mannheim University Medical Center, Mannheim, Germany., Joensuu H; Helsinki University Hospital (HUH) and University of Helsinki, Helsinki, Finland., Jones RL; Sarcoma Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Jungels C; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Jutte P; University Medical Center Groningen, Groningen, The Netherlands., Kager L; St. Anna Children's Hospital and Children's Cancer Research Institute (CCRI), Department of Pediatrics and Medical University Vienna Children's Cancer Research Institute, Vienna, Austria., Kasper B; Mannheim University Medical Center, Mannheim, Germany., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Kopeckova K; University Hospital Motol, Prague, Czech Republic., Krákorová DA; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Le Grange F; Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK., Legius E; Department for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Leithner A; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria., López Pousa A; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain., Martin-Broto J; Department of Medical Oncology, Fundación Jimenez Diaz, University Hospital, Advanced Therapies in Sarcoma Lab, Madrid, Spain., Merimsky O; Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel., Messiou C; Department of Radiology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Miah AB; Department of Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Mir O; Department of Ambulatory Cancer Care, Gustave Roussy, Villejuif, France., Montemurro M; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Morland B; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Morosi C; Department of Radiology, IRCCS Foundation National Cancer Institute, Milan, Italy., Palmerini E; Department of Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Pantaleo MA; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria, di Bologna, Bologna, Italy., Piana R; Azienda Ospedaliero, Universitaria Cita della Salute e della Scienza di Torino, Turin, Italy., Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France., Reichardt P; Helios Klinikum Berlin Buch, Berlin, Germany., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Safwat AA; Aarhus University Hospital, Aarhus, Denmark., Sangalli C; Department of Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sbaraglia M; Department of Pathology, Azienda Ospedale Università Padova, Padua, Italy., Scheipl S; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria., Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Strauss D; Department of Surgery, Royal Marsden Hospital, London, UK., Sundby Hall K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Trama A; Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Unk M; Institute of Oncology of Ljubljana, Ljubljana, Slovenia., van de Sande MAJ; Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Frebourg T; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Ladenstein R; University Medical Center Groningen, Groningen, The Netherlands., Casali PG; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Oncology and Hemato-oncology University of Milan, Milan, Italy., Stacchiotti S; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Dec; Vol. 32 (12), pp. 1520-1536. Date of Electronic Publication: 2021 Sep 06.

Communication with cancer patient.

Autor: Halámková J, Sláma O, Krákorová DA, Demlová R, Kuře J

Publikováno v: Vnitrni lekarstvi [Vnitr Lek] 2019 Spring; Vol. 65 (5), pp. 359-362.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Autor: Casali PG; Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Abecassis N; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon, Portugal., Aro HT; Turku University Hospital (Turun Yliopistollinen Keskussairaala), Turlu, Finland., Bauer S; University Hospital Essen, Essen Germany., Biagini R; Department of Oncological Orthopedics, Musculoskeletal Tissue Bank, IFO, Regina Elena National Cancer Institute, Rome, Italy., Bielack S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany., Bonvalot S; Institut Curie, Paris, France., Boukovinas I; NORDIX, Athens, Greece., Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Brodowicz T; Vienna General Hospital (AKH), Medizinische Universität Wien, Vienna, Austria., Broto JM; Hospital Universitario Virgen del Rocio-CIBERONC, Seville, Spain., Buonadonna A; Centro di Riferimento Oncologico di Aviano, Aviano., De Álava E; Hospital Universitario Virgen del Rocio-CIBERONC, Seville, Spain., Dei Tos AP; Ospedale Regionale di Treviso 'S.Maria di Cà Foncello', Treviso, Italy., Del Muro XG; Integrated Unit ICO Hospitalet, HUB, Barcelona, Spain., Dileo P; Sarcoma Unit, University College London Hospitals, London, UK., Eriksson M; Skane University Hospital-Lund, Lund, Sweden., Fedenko A; N. N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation., Ferraresi V; Institute of Scientific Hospital Care (IRCCS), Regina Elena National Cancer Institute, Rome., Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan., Ferrari S; Istituto Ortopedico Rizzoli, Bologna., Frezza AM; Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Gasperoni S; Azienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Gil T; Institut Jules Bordet, Brussels, Belgium., Grignani G; Candiolo Cancer Institute, FPO IRCCS, Candiolo, Italy., Gronchi A; Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Haas RL; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam and Department of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands., Hassan B; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Hohenberger P; Mannheim University Medical Center, Mannheim., Issels R; Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany., Joensuu H; Helsinki University Central Hospital (HUCH), Helsinki, Finland., Jones RL; Royal Marsden Hospital, London., Judson I; The Institute of Cancer Research, London, UK., Jutte P; University Medical Center Groningen, Groningen., Kaal S; Radboud University Medical Center, Nijmegen, The Netherlands., Kasper B; Mannheim University Medical Center, Mannheim., Kopeckova K; University Hospital Motol, Prague., Krákorová DA; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Le Cesne A; Gustave Roussy Cancer Campus, Villejuif, France., Lugowska I; Maria Sklodowska Curie Institute, Oncology Centre, Warsaw, Poland., Merimsky O; Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel., Montemurro M; Medical Oncology, University Hospital of Lausanne, Lausanne, Switzerland., Pantaleo MA; Azienda Ospedaliera, Universitaria, Policlinico S Orsola-Malpighi Università di Bologna, Bologna., Piana R; Azienda Ospedaliero, Universitaria Cita della Salute e della Scienza di Torino, Turin, Italy., Picci P; Istituto Ortopedico Rizzoli, Bologna., Piperno-Neumann S; Institut Curie, Paris, France., Pousa AL; Fundacio de Gestio Sanitaria de L'hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Reichardt P; Helios Klinikum Berlin Buch, Berlin, Germany., Robinson MH; YCRC Department of Clinical Oncology, Weston Park Hospital NHS Trust, Sheffield, UK., Rutkowski P; Maria Sklodowska Curie Institute, Oncology Centre, Warsaw, Poland., Safwat AA; Aarhus University Hospital, Aarhus, Finland., Schöffski P; Leuven Cancer Institute, Leuven, Belgium., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Stacchiotti S; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy., Sundby Hall K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Unk M; Institute of Oncology of Ljubljana, Ljubljana, Slovenia., Van Coevorden F; Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van der Graaf WTA; Royal Marsden Hospital, London., Whelan J; University College Hospital, London, UK., Wardelmann E; Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster, Münster, Germany., Zaikova O; Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway., Blay JY; Centre Leon Bernard and UCBL1, Lyon, France.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Oct 01; Vol. 29 (Suppl 4), pp. iv68-iv78.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Autor: Casali PG; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan and University of Milan, Milan, Italy., Bielack S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany., Abecassis N; Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal., Aro HT; Turku University Hospital (Turun Yliopistollinen Keskussairaala), Turlu, Finland., Bauer S; University Hospital Essen, Essen, Germany., Biagini R; Department of Oncological Orthopedics, Musculoskeletal Tissue Bank, IFO, Regina Elena National Cancer Institute, Rome, Italy., Bonvalot S; Institut Curie, Paris, France., Boukovinas I; Bioclinic Thessaloniki, Thessaloniki, Greece., Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Brennan B; Royal Manchester Children's Hospital, Manchester, UK., Brodowicz T; Vienna General Hospital (AKH), Medizinische Universität Wien, Vienna, Austria., Broto JM; Hospital Universitario Virgen del Rocio-CIBERONC, Seville, Spain., Brugières L; Gustave Roussy Cancer Campus, Villejuif, France., Buonadonna A; Centro di Riferimento Oncologico di Aviano, Aviano., De Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital /CSIC/University of Sevilla/CIBERONC, Seville, Spain., Dei Tos AP; Ospedale Regionale di Treviso 'S.Maria di Cà Foncello', Treviso, Italy., Del Muro XG; Integrated Unit ICO Hospitalet, HUB, Barcelona, Spain., Dileo P; Sarcoma Unit, University College London Hospitals NHS Trust, London, UK., Dhooge C; Ghent University Hospital (Pediatric Hematology-Oncology & Stem Cell Transplantation), Ghent, Belgium., Eriksson M; Skane University Hospital-Lund, Lund, Sweden., Fagioli F; Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, Italy., Fedenko A; N. N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation., Ferraresi V; Department of Oncological Orthopedics, Musculoskeletal Tissue Bank, IFO, Regina Elena National Cancer Institute, Rome, Italy., Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan., Ferrari S; Istituto Ortopedico Rizzoli, Bologna., Frezza AM; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy., Gaspar N; Gustave Roussy Cancer Campus, Villejuif, France., Gasperoni S; Azienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Gil T; Institut Jules Bordet, Brussels, Belgium., Grignani G; Candiolo Cancer Institute, FPO IRCCS, Candiolo, Italy., Gronchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan and University of Milan, Milan, Italy., Haas RL; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam and Department of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands., Hassan B; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Hecker-Nolting S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany., Hohenberger P; Mannheim University Medical Center, Mannheim., Issels R; Department of Medicine III, University Hospital Ludwig-Maximilians-University Munich, Munich, Germany., Joensuu H; Helsinki University Central Hospital (HUCH), Helsinki, Finland., Jones RL; Royal Marsden Hospital, London., Judson I; The Institute of Cancer Research, London, UK., Jutte P; University Medical Center Groningen, Groningen., Kaal S; Radboud University Medical Center, Nijmegen, The Netherlands., Kager L; St. Anna Children's Hospital & Children's Cancer Research Institute, Medical University Vienna, Vienna, Austria., Kasper B; Mannheim University Medical Center, Mannheim., Kopeckova K; University Hospital Motol, Prague., Krákorová DA; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Ladenstein R; St. Anna Children's Hospital & Children's Cancer Research Institute, Medical University Vienna, Vienna, Austria., Le Cesne A; Gustave Roussy Cancer Campus, Villejuif, France., Lugowska I; Maria Sklodowska Curie Institute-Oncology Centre, Warsaw, Poland., Merimsky O; Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel., Montemurro M; Medical Oncology University Hospital of Lausanne, Lausanne, Switzerland., Morland B; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Pantaleo MA; Azienda Ospedaliera, Universitaria, Policlinico S Orsola-Malpighi Università di Bologna, Bologna, Italy., Piana R; Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, Italy., Picci P; Istituto Ortopedico Rizzoli, Bologna., Piperno-Neumann S; Institut Curie, Paris, France., Pousa AL; Fundacio de Gestio Sanitaria de L'Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Reichardt P; Helios Klinikum Berlin Buch, Berlin, Germany., Robinson MH; YCRC Department of Clinical Oncology, Weston Park Hospital NHS Trust, Sheffield, UK., Rutkowski P; Maria Sklodowska Curie Institute-Oncology Centre, Warsaw, Poland., Safwat AA; Aarhus University Hospital, Aarhus, Finland., Schöffski P; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Stacchiotti S; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy., Strauss SJ; Sarcoma Unit, University College London Hospitals NHS Trust, London, UK., Sundby Hall K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Unk M; Institute of Oncology of Ljubljana, Ljubljana, Slovenia., Van Coevorden F; Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van der Graaf WTA; Royal Marsden Hospital, London.; Radboud University Medical Center, Nijmegen, The Netherlands.; Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Whelan J; Sarcoma Unit, University College London Hospitals NHS Trust, London, UK., Wardelmann E; Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster, Münster, Germany., Zaikova O; Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Blay JY; Centre Leon Bernard and UCBL1, Lyon, France.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Oct 01; Vol. 29 (Suppl 4), pp. iv79-iv95.